Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
Gilad Karavani, Henry H. Chill, Aharon Dick, Cherut Meirman, Einat Gutman‐Ido, Shmuel Herzberg, Assaf Ben‐Meir, Tal Imbar
Topics & Concepts
VaccinationMedicinePandemicCryopreservationGynecologyCohortCoronavirus disease 2019 (COVID-19)Internal medicineImmunologyBiologyEmbryoCell biologyDiseaseInfectious disease (medical specialty)COVID-19 Impact on ReproductionReproductive Biology and FertilityOvarian function and disorders